Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Liver Neoplasms 1Disease 1Colorectal Neoplasms 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Cisplatin 12Irinotecan 10Specimen Handling 8Fluorouracil 8Oxaliplatin 7Magnetic Resonance Spectroscopy 6Trastuzumab 5Leucovorin 5Capecitabine 5Biopsy 5Neoadjuvant Therapy 4Docetaxel 4fludarabine 3Radiotherapy 3Paclitaxel 3Interleukin-12 Subunit p35 3Epirubicin 3Cyclophosphamide 3Chemotherapy, Adjuvant 3trastuzumab deruxtecan 2talazoparib 2bryostatin 1 2aldesleukin 2X-Rays 2Psychiatric Rehabilitation 2Platinum 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Microarray Analysis 2Magnetic Resonance Imaging 2MK 2206 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Stomach Neoplasms × TKM-080301 × Clear all
NCT01437007 2018-08-03

TKM 080301 for Primary or Secondary Liver Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
1 enrolled
BreastGastrointestinalGynecologic

Adenocarcinoma, Breast Neoplasms, Disease, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡